301 3rd Floor Aura Biplex,SV Road Borivali(West),

Mumbai - 400092,

Maharashtra, India.

Phone : 91-22-42221111

Fax : NA

Email :  compliance.spil@gmail.com

Website :  www.sudarshanpharma.com

Public issue of 68,62,400 equity shares of face value of (Rs) 10.00 each ("Equity Shares") of Sudarshan Pharma Industries Limited (the "Company" or the "Issuer") for cash at a price of (Rs) 73.00 per equity share including a share premium of (Rs) 63.00 per equity share (the "Issue Price") aggregating to (Rs) 50.10 crores ("The Issue") of which 3,44,000 equity shares aggregating to (Rs) 2.51 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 65,18,400 equity shares aggregating to (Rs) 47.59 crores (the "Net Issue"). The issue and the net issue will constitute 28.52% and 27.09% respectively of the post issue paid-up equity share capital of the company. Issue Price : (Rs) 73 per equity share of face value of (Rs) 10 each. Anchor Investor Issue Price : (Rs) 73 per equity shares The issue price is 7.3 times of the face value. Bids can be made for a minimum of 1600 equity shares and in multiples of 1600 equity shares thereafter.

Minimum Application for shares in Nos : 1600   Further Multiples of : 1600